Nausea
📧 Sign up to get email alerts when something new happens for Nausea.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-25EMA Authorised: Akynzeo (netupitant;palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd
The EMA authorised Akynzeo (netupitant and palonosetron hydrochloride) for vomiting, nausea, cancer-related indications.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting [Phase 3]
Phase 3 clinical trial evaluating olanzapine plus metoclopramide to prevent opioid-induced nausea and vomiting is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Noninvasive Markers of Functional Nausea in Children [EARLY_Phase 1]
An early-phase pediatric trial evaluating noninvasive markers for functional nausea in children has completed. The study may yield biomarker…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Biomagnetic Characterization of Gastric Dysrhythmias III [EARLY_Phase 1]
This update notes the completion of an early-phase 1 study at Vanderbilt University Medical Center investigating biomagnetic characterizatio…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use [Phase 3]
Phase 3 study evaluating Tradipitant for nausea and vomiting induced by GLP-1 receptor agonist use in obesity is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Outpatient Oncology Aromatherapy for Symptom Management [NA]
A completed outpatient oncology trial evaluated aromatherapy for managing anxiety and nausea symptoms in cancer patients.
-
FDA approval · 2026-04-01FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for PROCHLORPERAZINE EDISYLATE (ANDA212257) filed by Somerset Therapeutics, LLC. This approval relat…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Inhaled Isopropyl Alcohol for Treatment of Nausea [Phase 2, Phase 3]
Clinical trial evaluating inhaled isopropyl alcohol for nausea and vomiting is in Phase 2/3 and currently recruiting, with enrollment limite…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea) [Phase 3]
HALEON's Phase 3 trial assessing ENO Lime for indigestion symptoms (acidity/acid indigestion and associated nausea) has completed.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash [NA]
An update on a clinical trial evaluating a protective oral care protocol using peppermint oil mouthwash for patients with hematologic neopla…
-
FDA approval · 2025-09-08FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original ANDA for prochlorperazine maleate, allowing the generic antiemetic/antipsychotic to be …
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Norepinephrine ED90 Bolus After Spinal Anesthesia in Cesarean Section [Phase 4]
Phase 4 trial evaluating the efficacy and safety of a norepinephrine ED90 bolus to prevent or treat spinal anesthesia–associated hypotension…
-
CLINICAL_TRIALS withdrawal · 2025-07-29Clinical Trial Update: Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT [Phase 4]
A Phase 4 randomized trial comparing haloperidol with diphenhydramine versus metoclopramide with diphenhydramine for acute headaches (migrai…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers [Phase 1]
Phase 1 clinical trial assessing pharmacokinetics and bioequivalence of Doxylamine+Pyridoxine (Diclectin) under fed conditions in healthy vo…
-
FDA approval · 2025-06-24FDA Approved: PROMETHAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for promethazine hydrochloride from Hikma Pharmaceuticals USA, confirming the approval of a generic …
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Inhaled Isopropyl Alcohol Versus Placebo to Manage Nausea at Electronic Dance Music Festivals [NA]
A completed clinical trial tested inhaled isopropyl alcohol versus placebo for nausea relief in festival environments.
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for PROCHLORPERAZINE MALEATE by Ajanta Pharma USA Inc. under the ANDA pathway.
-
FDA approval · 2024-09-13FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original ANDA for Prochlorperazine Edisylate from Somerset Therapeutics, LLC, authorizing its marketing as an antiemetic fo…
-
FDA label_change · 2023-12-27FDA Approved: PROMETHAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Promethazine hydrochloride from Hikma Pharmaceuticals USA, authorizing changes to the product la…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders [NA]
A terminated randomized sham-controlled pediatric trial evaluating auricular TENS stimulation for functional gastrointestinal disorders; res…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Haloperidol for the Treatment of Nausea and Vomiting in the ED [Phase 4]
Phase 4 trial update evaluating haloperidol for nausea and vomiting in the emergency department has completed.
-
FDA approval · 2023-05-01FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited, approving this generic an…
-
FDA approval · 2023-04-04FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (Bionpharma Inc.)
FDA approved an Original Application for Prochlorperazine Maleate from Bionpharma Inc., authorizing its marketing as a generic antiemetic.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV [Phase 3]
A Phase 3 clinical trial evaluating CL-108 5 mg for acute pain and prevention of opioid-induced nausea/vomiting has completed with posted re…
-
FDA approval · 2023-03-17FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Prochlorperazine maleate from Glenmark Pharmaceuticals under an Original Application; it is an antiemetic indicated to prevent …